Table of contents

Hepatitis

• Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection (19 November, 2007)

  G V Papatheodoridis, E Hadziyannis, E Tsochatzis, N Chrysanthos, A Georgiou, G Kafiri, S Manolakopoulos, D G Tiniakos, I Giannousis, E K Manesis, A J Archimandritis
• Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C (19 September, 2007)

  M Persico, M Capasso, R Russo, E Persico, L Crocè, C Tiribelli, A Iolascon
• Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C (25 September, 2007) Free

  T Asselah, I Bieche, S Narguet, A Sabbagh, I Laurendeau, M-P Ripault, N Boyer, M Martinot-Peignoux, D Valla, M Vidaud, P Marcellin
• Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: a randomised study (19 September, 2007)

  C-H Liu, C-C Liang, J-W Lin, S-I Chen, H-B Tsai, C-S Chang, P-H Hung, J-H Kao, C-J Liu, M-Y Lai, J-H Chen, P-J Chen, J-H Kao, D-S Chen
• Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study (13 December, 2007)

  M R Kraus, A Schäfer, K Schöttker, C Keicher, B Weissbrich, I Hofbauer, M Scheurlen